Sensei Biotherapeutics (NASDAQ:SNSE – Get Free Report) is expected to be releasing its earnings data before the market opens on Wednesday, February 26th. Analysts expect Sensei Biotherapeutics to post earnings of ($0.27) per share for the quarter.
Sensei Biotherapeutics Price Performance
SNSE opened at $0.45 on Monday. Sensei Biotherapeutics has a one year low of $0.38 and a one year high of $1.94. The firm has a market capitalization of $11.33 million, a price-to-earnings ratio of -0.38 and a beta of 0.17. The business has a 50 day simple moving average of $0.49 and a two-hundred day simple moving average of $0.52.
Wall Street Analysts Forecast Growth
Separately, HC Wainwright reissued a “buy” rating and issued a $4.00 price target on shares of Sensei Biotherapeutics in a research note on Wednesday, January 8th.
Sensei Biotherapeutics Company Profile
Sensei Biotherapeutics, Inc, an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. The company's Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment.
Featured Stories
- Five stocks we like better than Sensei Biotherapeutics
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- What Are the FAANG Stocks and Are They Good Investments?
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- 3 Tickers Leading a Meme Stock Revival
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Receive News & Ratings for Sensei Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensei Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
